391 related articles for article (PubMed ID: 26893065)
1. Effects of Physician-directed Pharmaceutical Promotion on Prescription Behaviors: Longitudinal Evidence.
Datta A; Dave D
Health Econ; 2017 Apr; 26(4):450-468. PubMed ID: 26893065
[TBL] [Abstract][Full Text] [Related]
2. Association Between Academic Medical Center Pharmaceutical Detailing Policies and Physician Prescribing.
Larkin I; Ang D; Steinhart J; Chao M; Patterson M; Sah S; Wu T; Schoenbaum M; Hutchins D; Brennan T; Loewenstein G
JAMA; 2017 May; 317(17):1785-1795. PubMed ID: 28464141
[TBL] [Abstract][Full Text] [Related]
3. Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review.
Fickweiler F; Fickweiler W; Urbach E
BMJ Open; 2017 Sep; 7(9):e016408. PubMed ID: 28963287
[TBL] [Abstract][Full Text] [Related]
4. Influence of pharmaceutical promotion on prescribers in Jordan.
Altawalbeh SM; Ibrahim IA; Al-Shatnawi SF
Int J Clin Pharm; 2020 Apr; 42(2):744-755. PubMed ID: 32140917
[TBL] [Abstract][Full Text] [Related]
5. Characterizing the relationship between free drug samples and prescription patterns for acne vulgaris and rosacea.
Hurley MP; Stafford RS; Lane AT
JAMA Dermatol; 2014 May; 150(5):487-93. PubMed ID: 24740450
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical marketing strategies' influence on physicians' prescribing pattern in Lebanon: ethics, gifts, and samples.
Khazzaka M
BMC Health Serv Res; 2019 Jan; 19(1):80. PubMed ID: 30700295
[TBL] [Abstract][Full Text] [Related]
7. The impact of a physician detailing and sampling program for generic atorvastatin: an interrupted time series analysis.
Worthington HC; Cheng L; Majumdar SR; Morgan SG; Raymond CB; Soumerai SB; Law MR
Implement Sci; 2017 Nov; 12(1):141. PubMed ID: 29178960
[TBL] [Abstract][Full Text] [Related]
8. What influences healthcare providers' prescribing decisions? Results from a national survey.
Price SM; O'Donoghue AC; Rizzo L; Sapru S; Aikin KJ
Res Social Adm Pharm; 2021 Oct; 17(10):1770-1779. PubMed ID: 33558154
[TBL] [Abstract][Full Text] [Related]
9. Effect of drug sample removal on prescribing in a family practice clinic.
Hartung DM; Evans D; Haxby DG; Kraemer DF; Andeen G; Fagnan LJ
Ann Fam Med; 2010; 8(5):402-9. PubMed ID: 20843881
[TBL] [Abstract][Full Text] [Related]
10. Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data.
Sharma M; Vadhariya A; Johnson ML; Marcum ZA; Holmes HM
BMC Health Serv Res; 2018 Apr; 18(1):236. PubMed ID: 29609611
[TBL] [Abstract][Full Text] [Related]
11. Generic entry, reformulations and promotion of SSRIs in the US.
Huskamp HA; Donohue JM; Koss C; Berndt ER; Frank RG
Pharmacoeconomics; 2008; 26(7):603-16. PubMed ID: 18563951
[TBL] [Abstract][Full Text] [Related]
12. Physician characteristics, industry transfers, and pharmaceutical prescribing: Empirical evidence from medicare and the physician payment sunshine act.
Brunt CS
Health Serv Res; 2019 Jun; 54(3):636-649. PubMed ID: 30273976
[TBL] [Abstract][Full Text] [Related]
13. The Association of Industry Payments to Physicians with Prescription of Brand-Name Intranasal Corticosteroids.
Morse E; Fujiwara RJT; Mehra S
Otolaryngol Head Neck Surg; 2018 Sep; 159(3):442-448. PubMed ID: 29865931
[TBL] [Abstract][Full Text] [Related]
14. Prescriber profiles.
Capozzi JD; Rhodes R
J Bone Joint Surg Am; 2001 Jul; 83(7):1115-6. PubMed ID: 11451989
[TBL] [Abstract][Full Text] [Related]
15. Physician prescribing behavior and its impact on patient-level outcomes.
Joyce GF; Carrera MP; Goldman DP; Sood N
Am J Manag Care; 2011 Dec; 17(12):e462-71. PubMed ID: 22216870
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting general practitioners' decisions to adopt new prescription drugs - cohort analyses using Australian longitudinal physician survey data.
Zhang Y; Méndez SJ; Scott A
BMC Health Serv Res; 2019 Feb; 19(1):94. PubMed ID: 30728010
[TBL] [Abstract][Full Text] [Related]
17. Impact of e-detailing on the number of new prescriptions.
Gönül FF; Carter FJ
Health Care Manag Sci; 2010 Jun; 13(2):101-11. PubMed ID: 20629413
[TBL] [Abstract][Full Text] [Related]
18. Drug promotional activities in Nigeria: impact on the prescribing patterns and practices of medical practitioners and the implications.
Fadare JO; Oshikoya KA; Ogunleye OO; Desalu OO; Ferrario A; Enwere OO; Adeoti A; Sunmonu TA; Massele A; Baker A; Godman B
Hosp Pract (1995); 2018 Apr; 46(2):77-87. PubMed ID: 29426263
[TBL] [Abstract][Full Text] [Related]
19. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
20. Reconciling a "pleasant exchange" with evidence of information bias: A three-country study on pharmaceutical sales visits in primary care.
Reynolds E; Guénette L; Lexchin J; Cassels A; Wilkes MS; Durrieu G; Beaulieu MD; Mintzes B
Health Policy; 2018 Mar; 122(3):250-255. PubMed ID: 29395543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
